Nanobiotix (NBTX) Stock Price, Quote, News & History | Benzinga

SPY770.73+0.22%QQQ722.85+0.73%BTC/USD82,729.60−0.25%DIA524.31−0.01%GLD377.24−0.11%TLT79.93−0.25%

Nanobiotix SA (NBTX) Stock Price, Quote, News & History

NBTXNASDAQ

Trade with Public

Trade with Public

$24.14

3.0614.52%

Last update: Oct 20, 9:29 AM

$21.48

0.401.9%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$21.45

Close

$24.14

Volume / Avg.

137.90K / 149.72K

Day Range

$21.45 - $24.51

52 Wk Range

14.78 - 57.14

Market Cap

$1.09B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

0.39%

Days to Cover

1.04

Recent Nanobiotix SA News

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other stocks rallied on strong results.

Avi Kapoor

XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures lower with Nasdaq down 200 points. XP Inc (XP) falls after reporting lower-than-expected earnings and naming new CFO. Other stocks also trading lower.

Avi Kapoor

Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market trading include AMST, HAO, MTVA, ONCO, SDA, PIII, VRAX, PURR, BKKT, WOK, BTM, and UBXG.

Avi Kapoor

Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.

Avi Kapoor

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

Nanobiotix rejects takeover talk after J&J speculation; stock jumps as analysts weigh momentum strength against mixed technical signals.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-34.19M

Investing Cash Flow (TTM)

-989.00K

Financing Cash Flow (TTM)

116.74M

Free Cash Flow (TTM)

-35.20M

Capital Expenditure (TTM)

-1.01M

Net Change in Cash (TTM)

81.56M

Analyst Trends and Forecast

1

May

1

Jun

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.07B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

109.87

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-5.76%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.74

Company Debt

Total Debt

$104.11M

LT Debt

$73.28M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$4.39M

Total Cash

$110.89M

Debt to Equity

-

Issuance of Debt (TTM)

$38.54M

Repayment of Debt (TTM)

-$4.39M